Literature DB >> 7659163

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).

P Macchi1, A Villa, S Giliani, M G Sacco, A Frattini, F Porta, A G Ugazio, J A Johnston, F Candotti, J J O'Shea.   

Abstract

Severe combined immune deficiency (SCID) represents a heterogenous group of hereditary diseases. Mutations in the common gamma-chain (gamma c), which is part of several cytokine receptors including those for interleukin (IL)-2, IL-4, IL-7, IL-9 and IL-15, are responsible for X-linked SCID, which is usually associated with a lack of circulating T cells and the presence of B lymphocytes (T- B+ SCID). The gene(s) responsible for autosomal recessive T- B+ SCID is still unknown. The Jak-3 protein kinase has been found to associate with the gamma c-chain-containing cytokine receptors. Therefore Jak-3 or other STAT proteins with which it interacts are candidate genes for autosomal recessive T- B+ SCID. Here we investigate two unrelated T- B+ SCID patients (both from consanguineous parents) who have homozygous mutations in the gene for Jak-3. One patient carries a mutation (Tyr100-->Cys) in a conserved tyrosine residue in the JH7 domain of Jak-3 which is absent in more than 150 investigated chromosomes. The other patient carries a homozygous 151-base-pair deletion in the kinase-like domain, leading to a frameshift and premature termination. Both mutations resulted in markedly reduced levels of Jak-3. These findings show that abnormalities in the Jak/STAT signalling pathway can account for SCID in humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7659163     DOI: 10.1038/377065a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  203 in total

Review 1.  Severe combined immunodeficiency--molecular pathogenesis and diagnosis.

Authors:  H B Gaspar; K C Gilmour; A M Jones
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

Review 2.  Interleukin-2 signaling and inherited immunodeficiency.

Authors:  N A Cacalano; J A Johnston
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

Review 3.  Severe combined immunodeficiencies (SCID).

Authors:  A Fischer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 4.  Jaks and stats as therapeutic targets.

Authors:  J J O'Shea; R Visconti; T P Cheng; M Gadina
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 5.  Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways.

Authors:  Fabio Candotti; Luigi Notarangelo; Roberta Visconti; John O'Shea
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

6.  Differential requirement of the cytoplasmic subregions of gamma c chain in T cell development and function.

Authors:  S Tsujino; J P Di Santo; A Takaoka; T L McKernan; S Noguchi; C Taya; H Yonekawa; T Saito; T Taniguchi; H Fujii
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

7.  Polarity determination in the Drosophila eye: a novel role for unpaired and JAK/STAT signaling.

Authors:  M P Zeidler; N Perrimon; D I Strutt
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

8.  Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.

Authors:  Q Zhang; P N Raghunath; E Vonderheid; N Odum; M A Wasik
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

9.  Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment.

Authors:  Federica Cattaneo; Mike Recher; Stefania Masneri; Sachin N Baxi; Claudia Fiorini; Francesca Antonelli; Christian A Wysocki; Jose G Calderon; Hermann Eibel; Angela R Smith; Francisco A Bonilla; Erdyni Tsitsikov; Silvia Giliani; Luigi D Notarangelo; Sung-Yun Pai
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

10.  Human lymphoid development in the absence of common γ-chain receptor signaling.

Authors:  Lisa A Kohn; Christopher S Seet; Jessica Scholes; Felicia Codrea; Rebecca Chan; Sania Zaidi-Merchant; Yuhua Zhu; Satiro De Oliveira; Neena Kapoor; Ami Shah; Hisham Abdel-Azim; Donald B Kohn; Gay M Crooks
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.